Eventos

Catalent and Barcelona Science Park present: De-risking small molecule early drug development with expert technology selection on which Catalent experts will provide insight into how to classify new therapeutic drug candidates for issues relating to oral product development, anticipate and address challenges early, and plan for success in preclinical and early-stage clinical studies.